|
Summary of antibodies tested on Western Blot |
|||||
| Antibody |
Overexpressed mLRRK2 |
Overexpressed hLRRK2 |
Endogenous mLRRK2 |
Endogenous hLRRK2 |
Peptide Location |
|
|
|||||
| Abgent AP7099a |
- |
- |
- |
- |
N/A |
| Abgent AP7099b |
- |
- |
- |
- |
(LRR, AA 1246–1265, 100% identity) H: WSRVEKLHLSHNKLKEIPPE M: WSRVEKLHLSHNKLKEIPPE |
| Abgent AP7099c |
- |
- |
- |
- |
(N-Term, around L229) H: EEIVLHVLHCLHSLAIPCNNVEVLMSGNVR M: KEIVYHVLCCLHSLAVTCSNVEVLMSGNVR |
| Abgent AP7099d |
- |
- |
- |
- |
(N-Term, around E285) H: VSCCLLHRLTLGNFFNILVLNEVHEFVVKA M: VSCSLFQKLTLGNFFNILVLNEVHVFVVKA |
| Abgent AP7099e |
- |
+ |
- |
+ |
(N-Term, around E519) H: RAILHFIVPGMPEESREDTEFHHKLNMVKK M: RAILHFVVPGLLEESRE..DSQCRPNVLRK |
| Abgent AP7099f |
- |
+ |
- |
- |
(N-Term, around L893) H: AQSDDLDSEGSEGSFLVKKKSNSISVGEFY M: GQSDDLDSEGSESSFLVKRKSNSISVGEVY |
| Abgent AP7099g |
- |
+ |
- |
- |
(N-Term, around L899) H: AQSDDLDSEGSEGSFLVKKKSNSISVGEFY M: GQSDDLDSEGSESSFLVKRKSNSISVGEVY |
| Abgent AP7099h |
- |
+ |
- |
- |
(N-Term, around L955) H: IFDHEDLLKRKRKILSSDDSLRSSKLQSHM M: VFDHEDLLRRKRKILSSDESLRSSRLPSHM |
| Abgent AP7099i |
- |
- |
- |
- |
(C-Term, around C2354) H: STERNVMWGGCGTKIFSFSNDFTIQKLIET M: SSERHITWGGCGTKVFSFSNDFTIQKLIET |
| Abgent AP7099j |
- |
- |
- |
- |
(C-Term, around K2402) H: CVHFLREVMVKENKESKHKMSYSGRVKTLC M: CVHFLKEVMVKLNKESKHQLSYSGRVKALC |
| Abgent AP7099k |
- |
- |
- |
- |
(C-Term, around Y2475) H: MTAQLGSLKNVMLVLGYNRKNTEGTQKQKE M: ATAQLGSLKNVMLVLGYKRKSTEGIQEQKE |
| Abgent AM7099a |
- |
- |
- |
- |
(monoclonal) N/A |
| Abgent AM7099b |
- |
- |
- |
- |
(monoclonal) N/A |
| Abcam 27482 |
- |
+ |
- |
- |
N/A |
| Abcam 19906 |
- |
- |
- |
- |
N/A |
| Novus Biological 267 |
- |
+ |
- |
+ |
(N-Term, AA 920–945) H: SNSISVGEFYRDAVLQRCSPNLQRHS M: SNSISVGEVYRDLALQRYSPNAQRHS |
| Novus Biological 268 |
- |
+ |
- |
+ |
(C-Term, AA 2500–2527) H: INLPHEVQNLEKHIEVRKELAEKMRRTSVE M: LNLPHEVQNLEKHIEVRTELADKMRKTSVE |
| Chemicon AB9682 |
- |
+ |
- |
- |
N/A, synthetic peptide from rat |
| Chemicon AB9704 |
- |
+ |
- |
- |
N/A |
| Alexis (AT106) |
+ |
+ |
+ |
+ |
(AA 1838–2133) |
| Cell Signaling 2567 |
+ |
+ |
- |
- |
(C-Term, G2090) H: FPNEFDELEIQGKLPDPVKEYGCAPWPMVE M: FPNEFDELAIQGKLPDPVKEYGCAPWPMVE |
| JH5514 |
+ |
+ |
+ |
+ |
(C-Term, AA 2500–2515), 100% identity H: INLPHEVQNLEKHIE M: LNLPHEVQNLEKHIE |
|
Summary of the results of commercially available antibodies against LRRK2 tested on Western Blot. A (+) denotes antibodies that produce a discernable band specific to LRRK2 protein. A (-) denotes antibodies unable to detect a band specific to LRRK2 protein. Antibodies were designed against the human sequence unless otherwise indicated. | |||||
Biskup et al. BMC Neuroscience 2007 8:102 doi:10.1186/1471-2202-8-102 |
|||||